Int J Colorectal Dis (2017) 32:1363–1364 DOI 10.1007/s00384-017-2829-1 LETTER TO THE EDITOR 1 1 2 Davide Giuseppe Ribaldone & Marco Astegiano & Rinaldo Pellicano Accepted: 27 April 2017 /Published online: 4 May 2017 Springer-Verlag Berlin Heidelberg 2017 Dear Editor: A recent interesting retrospective study was performed in A systematic review has reported that, in Crohn’sdis- 383 newly diagnosed (not treated) CD patients. One patient ease (CD) patients, the prevalence of cholelithiasis ranged with chronic liver disease (small-duct PSC) was excluded. Of from 11 to 34%, that of primary sclerosing cholangitis the 383 patients included in this study, 131 had liver test ab- normalities (34.1%), but liver diseases were not found, apart (PSC) from 1.2 to 3.4%, that of fatty liver disease 23%, and hepatic amyloidosis occurred in <1% . In a prospec- from liver steatosis in 6% of patients (versus 29%in the tive, single-blind study, we evaluated the prevalence of previous study ). histological changes in the liver of patients with CD, with- The two studies [2, 3] agree that, considering the out alterations of both liver biochemical tests and ultra- cost/benefit ratio, patients with CD should be considered as sound, and their prognostic significance. The patients healthy from
International Journal of Colorectal Disease – Springer Journals
Published: May 4, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera